
Sheel Biotech
September 30, 2025 – October 3, 2025
Price | ₹59 - ₹63 |
GMP Rumors * | ₹0 |
---|---|
Lot size | 2000 |
Allotment | Oct 6, 2025 |
Listing | Oct 8, 2025 |
Sheel Biotech Lot(s) Distribution
Category | Lot(s) | Qty | Amount | Reserved |
---|---|---|---|---|
INDIVIDUAL | 2 | 4000 | 252000 | 0 |
sHNI | 3 | 6000 | 378000 | 0 |
bHNI | 8 | 16000 | 1008000 | 0 |
Sheel Biotech Reservation
Category | Shares Offered | % |
---|---|---|
Total | 0 | 100% |
Sheel Biotech About
Sheel Biotech IPO Details as per DRHP
Issue Size | 54,00,000 shares (aggregating up to ₹34.02 Cr) |
Fresh Issue | 54,00,000 shares (aggregating up to ₹34.02 Cr) |
Issue Type | Bookbuilding IPO |
Listing At | NSE SME |
Share Holding Pre Issue | 1,49,52,550 shares |
Share Holding Post Issue | 2,03,52,550 shares |
Reserved for Market Maker | 2,72,000 shares (aggregating up to ₹1.71 Cr) |
Sheel Biotech IPO Reservation
Investor Category | Shares Offered |
---|---|
QIB Shares Offered | Not more than 50% of the Net Issue |
Retail Shares Offered | Not less than 35% of the Net Issue |
NII Shares Offered | Not less than 15% of the Net Issue |
Key Performance Indicators (KPI)
Details will be added soon.Company Financials In Crores
Period | May 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|---|
Assets | 105.98 | 105.95 | 93.89 | 93.08 |
Income | 3.99 | 92.55 | 80.19 | 71.07 |
Profit | 0.48 | 10.51 | 5.08 | 4.51 |
Net Worth | 73.21 | 72.73 | 63.54 | 59.75 |
Reserves | 69.07 | 68.58 | 59.4 | 55.61 |
Borrowing | 25.22 | 23.54 | 19.17 | 23.58 |
Company Overview
Incorporated: November 1991
Business Focus: Biotechnology, floriculture, greenhouses, and organic projects
Core Offerings: Tissue culture plants, hydroponics, greenhouses, horticultural turnkey projects, landscaping, organic adoption & certification, FPO management, and skill development programs
Certifications: ISO 9001:2015, 14001:2015, 45001:2018
R&D Recognition: Department of Biotechnology (DBT) and Department of Science & Technology (DST), Govt. of India
Strength
Expertise in Biotechnology & Greenhouse Management – Skilled in advanced tissue culture, organic farming, and modern horticultural technologies.
Diverse Product & Service Portfolio – Ranging from planting material and turnkey greenhouse projects to organic certification, FPOs, and training.
Sustainability & Recognition – Eco-friendly practices with government-recognized R&D and international certifications for quality, safety, and environment.
Weakness
High Precision Requirement in Tissue Culture – Any lapse in sterilization, storage, or temperature control can cause contamination and heavy losses.
Tender Dependency in Organic Farming – Revenue is significantly reliant on securing government tenders, making the segment vulnerable to policy or tendering changes.
Operational Risk in Process Management – Even minor negligence in tissue culture techniques could disrupt the entire production cycle.
Sheel Biotech Lead Manager(s)
Sheel Biotech Address
8 Balaji Estates
, 2nd Floor, Block-C, Guru Ravidas Marg
Kalkaji
South Delhi, New Delhi, 110019
Phone: +91 88511 - 8980
Email: compliance@sheelbiotech.com
Website: http://www.sheelbiotech.com/
Sheel Biotech Registrar
Sheel Biotech Reviewers
Reviewer | Recommendation | File |
---|